数位脑健康市场－全球产业规模、份额、趋势、机会与预测：组成部分、功能、最终用户、地区和竞争格局（2021-2031年）

全球数位脑健康市场预计将从 2025 年的 2,236.1 亿美元大幅成长至 2031 年的 3,901.3 亿美元，复合年增长率为 9.72%。

该领域涵盖多种技术解决方案，包括用于评估和治疗神经系统疾病的诊断软体和数位疗法。市场成长的主要驱动力是全球人口老化和神经退化性疾病盛行率的不断上升，从而催生了对可扩展远距远端医疗方案的强劲需求。此外，专业人士的广泛应用也推动了这一成长。根据美国心理学会预测，到2025年，56%的心理学家将使用人工智慧工具辅助工作，这显示这些技术正逐渐融入标准临床实务。

然而，该行业面临着许多与监管核准所需的严格临床检验相关的重大障碍。达到与传统药物相同的证据标准是一个复杂的过程，这常常导致产品上市延迟，并限制了健保报销机会。此外，保护患者敏感的神经系统资料隐私仍然是一项持续的挑战。这些隐私问题可能会削弱用户信任，并使遵守国际卫生法规变得更加复杂，从而阻碍市场快速扩张。

市场驱动因素

神经系统和精神疾病盛行率的不断上升是全球数位脑健康市场的主要驱动力。随着预期寿命的延长，与老龄化相关的认知能力下降和慢性精神疾病的负担日益加重，给传统医疗保健系统带来了难以承受的压力，并迫切需要可扩展的数位干预措施。根据阿兹海默症协会于2025年3月发布的《2025年阿兹海默症健康状况报告》，预计约有720万65岁及以上的美国人患有老年痴呆症失智症，这凸显了便捷的远距监测和治疗工具的重要性。这种人口结构的变化正在推动模式转移，数位平台正成为临床和家庭环境中标准神经系统护理的重要组成部分。

同时，大量资金流入正在加速先进脑健康技术的研发和商业化。在技​​术成熟和清晰的商业化路径的支持下，投资者越来越认识到该领域的潜力。根据 Fierce Healthcare（2025 年 1 月）通报，2024 年，心理健康是美国数位健康市场中资金筹措最多的临床适应症，吸引了 14 亿美元的创业投资资金。这些资金对于进行严格的临床试验至关重要，而这些试验是获得监管部门核准和保险覆盖所必需的。此外，支付方政策的改善也增强了该领域的资金基础。根据《新英格兰心理学家》（2025 年 1 月）报道，联邦医疗保险（Medicare）已开始涵盖经 FDA核准的数位心理健康疗法。这是一个重要的监管里程碑，显着降低了投资风险，并促进了更多疗法进入市场。

市场挑战

全球数位脑健康市场受到严格的临床检验和监管合核准要求的显着限制。与典型的健康和保健应用程式不同，数位疗法和诊断软体必须透过与传统药物相同的证据标准来证明其安全性和有效性。这种高准入门槛要求进行大规模、高成本的临床试验，从而延缓了产品的商业化。由此导致的漫长研发週期阻碍了新解决方案的上市，并严重限制了永续收入模式和广泛应用所需的报销途径。

这种复杂性直接影响了专业人士的采纳率，因为医疗专业人员往往不愿意使用缺乏政府严格检验的工具。根据美国医学会 (AMA) 预测，到 2025 年，47% 的医生会将「加强法律规范」视为提升大众对医疗人工智慧工具信任度的首要步骤。除非人们对数位介入的临床有效性建立起坚实的信心，否则医疗服务提供者不太可能使用这些技术。这种怀疑态度造成了严重的通路瓶颈，有效地阻碍了市场快速扩张以满足日益增长的神经系统疾病治疗需求。

市场趋势

将人工智慧 (AI) 应用于预测分析和个人化治疗是推动全球数位脑健康市场发展的关键趋势，使製药公司能够优化治疗方案的研发和病人参与。利用先进演算法分析复杂资料集有助于识别数位生物标誌物，并开发传统调查方法难以实现的个人化介入策略。这种向数据驱动型精准医疗的转变，得益于製药业对运算能力的大规模投资。根据 Graphite Digital 于 2025 年 5 月发布的报告《2025 年製药业数位化趋势：人工智慧、全通路与病患参与》，68% 的製药业数位化决策者表示已投资于人工智慧驱动的洞察，这凸显了他们致力于利用机器学习技术来推进临床和营运的策略决心。

同时，随着雇主日益意识到员工心理健康对经济的影响，企业心理健康和认知韧性解决方案的成长正在推动市场扩张。各组织正积极采用数位化平台，为压力管理和认知能力提升提供扩充性的远端支持，有效地将职场转变为脑健康工具的主要通路。这种重视使得数位化介入措施能够惠及传统临床环境之外的更广泛人群。根据商业健康集团 (Business Group on Health) 于 2025 年 5 月发布的《2025 年雇主福祉战略调查》，100% 的受访大型企业已将心理健康纳入其福祉战略，47% 的企业将其列为计划中的首要组成部分，这证实了雇主主导的倡议在推动市场需求方面发挥着核心作用。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球数位脑健康市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 按组件（软体、装置）
  • 按功能分类（临床功能、行政功能、护理计划/健康管理、临床决策支援 (CDS)、电子健康记录 (EHR)、电子处方笺、财务功能、远端医疗、其他）
  • 依最终使用者（医院、诊所、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美数位脑健康市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲数位脑健康市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区数位脑健康市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲数位脑健康市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章 南美洲数位脑健康市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球数位脑健康市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Advanced Oncotherapy PLC
• Cerner Corporation
• Core Solutions, Inc.
• Danfysik A/S
• Hitachi Ltd
• Holmusk Inc
• IBA Worldwide
• Qualifacts Systems, Inc.
• International Business Machines Corporation
• Linus Health Inc

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Digital Brain Health Market is projected to expand significantly, growing from USD 223.61 Billion in 2025 to USD 390.13 Billion by 2031, reflecting a compound annual growth rate of 9.72%. This sector encompasses a range of technological solutions, such as diagnostic software and digital therapeutics, which are developed to assess and treat neurological conditions. The market's upward trajectory is primarily driven by an aging global population and the increasing prevalence of neurodegenerative disorders, creating a strong demand for scalable remote care options. Additionally, professional adoption is reinforcing this growth; according to the American Psychological Association, 56% of psychologists reported using artificial intelligence tools to assist with their work in 2025, demonstrating the integration of these technologies into standard clinical practice.

However, the industry faces substantial hurdles related to the rigorous clinical validation necessary for regulatory approval. Meeting evidence standards comparable to those of traditional pharmaceuticals is a complex process that frequently delays product launches and restricts reimbursement opportunities. Furthermore, safeguarding the privacy of sensitive patient neurological data remains a persistent challenge. These privacy concerns can erode user trust and complicate compliance with international health regulations, thereby impeding the rapid expansion of the market.

Market Driver

The escalating prevalence of neurological disorders and mental health conditions serves as the primary catalyst for the Global Digital Brain Health Market. As life expectancy rises, the increasing burden of age-related cognitive decline and chronic psychiatric issues is placing unsustainable pressure on traditional healthcare systems, creating an urgent need for scalable digital interventions. According to the Alzheimer's Association's '2025 Alzheimer's Disease Facts and Figures' report from March 2025, an estimated 7.2 million Americans aged 65 and older are living with Alzheimer's dementia, highlighting the critical necessity for accessible, remote monitoring and therapeutic tools. This demographic shift is forcing a paradigm change where digital platforms are becoming essential components of standard neurological care across both clinical and home settings.

Simultaneously, a strong influx of financial capital is accelerating the development and commercialization of advanced brain health technologies. Investors are increasingly recognizing the sector's potential, supported by technological maturity and clearer paths to monetization. According to Fierce Healthcare in January 2025, mental health remained the top-funded clinical indication in the U.S. digital health market in 2024, securing $1.4 billion in venture financing. This funding is vital for the rigorous clinical trials required for regulatory clearance and reimbursement eligibility. Moreover, the financial landscape is being bolstered by improved payer policies; according to New England Psychologist in January 2025, Medicare began covering FDA-approved digital mental health therapeutics, a regulatory milestone that significantly de-risks investment and encourages further market entry.

Market Challenge

The Global Digital Brain Health Market is significantly constrained by the rigorous clinical validation and regulatory compliance required for approval. Unlike general wellness applications, digital therapeutics and diagnostic software must demonstrate safety and efficacy through evidentiary standards comparable to traditional pharmaceuticals. This high barrier to entry necessitates extensive and costly clinical trials that delay product commercialization. Consequently, these extended development timelines slow the introduction of new solutions to the market and severely limit the availability of reimbursement pathways, which are critical for sustainable revenue models and widespread accessibility.

This complexity directly impacts professional adoption rates, as practitioners often hesitate to utilize tools that lack robust, government-backed verification. According to the American Medical Association, in 2025, 47% of physicians ranked increased regulatory oversight as the primary action necessary to improve their trust in healthcare AI tools. Without this established confidence in the clinical validity of digital interventions, providers are less likely to prescribe these technologies. This skepticism creates a substantial bottleneck in distribution, effectively preventing the market from scaling rapidly to meet the growing demand for neurological care.

Market Trends

The integration of Artificial Intelligence for predictive analytics and personalized treatment is a major trend driving the Global Digital Brain Health Market, enabling pharmaceutical companies to optimize therapeutic development and patient engagement. Advanced algorithms are utilized to analyze complex datasets, facilitating the identification of digital biomarkers and the creation of tailored intervention strategies that traditional methodologies cannot match. This shift towards data-driven precision medicine is evidenced by substantial industry investment in computational capabilities. According to Graphite Digital's 'Pharma Digital Trends 2025: AI, Omnichannel, & Patient Engagement' report from May 2025, 68% of senior digital decision-makers in the pharmaceutical industry reported investing in AI-powered insights, underscoring the sector's strategic commitment to leveraging machine learning for clinical and operational advancements.

Simultaneously, the growth of corporate mental wellness and cognitive resilience solutions is accelerating market expansion as employers increasingly recognize the economic impact of workforce psychological health. Organizations are actively adopting digital platforms to provide scalable, remote support for stress management and cognitive performance, effectively transitioning the workplace into a primary distribution channel for brain health tools. This prioritization ensures that digital interventions are accessible to a broader demographic beyond traditional clinical settings. According to the Business Group on Health's '2025 Employer Well-being Strategy Survey' released in May 2025, 100% of surveyed large employers included mental health in their well-being strategy, with 47% identifying it as the most important component of their program, confirming the central role of employer-sponsored initiatives in driving demand.

Key Market Players

• Advanced Oncotherapy PLC
• Cerner Corporation
• Core Solutions, Inc.
• Danfysik A/S
• Hitachi Ltd
• Holmusk Inc
• IBA Worldwide
• Qualifacts Systems, Inc.
• International Business Machines Corporation
• Linus Health Inc

Report Scope

In this report, the Global Digital Brain Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Digital Brain Health Market, By Components

• Software
• Devices

Digital Brain Health Market, By Functionalities

• Clinical Functionality
• Administrative Functionality
• Care Plans/Health Management
• Clinical Decision Support (CDS)
• Electronic Health Records (EHR)
• E-Prescribing
• Financial Functionality
• Telehealth
• Other

Digital Brain Health Market, By End-User

• Hospitals & Clinics
• Other

Digital Brain Health Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Digital Brain Health Market.

Available Customizations:

Global Digital Brain Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Digital Brain Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Components (Software, Devices)
  • 5.2.2. By Functionalities (Clinical Functionality, Administrative Functionality, Care Plans/Health Management, Clinical Decision Support (CDS), Electronic Health Records (EHR), E-Prescribing, Financial Functionality, Telehealth, Other)
  • 5.2.3. By End-User (Hospitals & Clinics, Other)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Digital Brain Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Components
  • 6.2.2. By Functionalities
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Digital Brain Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Components
      • 6.3.1.2.2. By Functionalities
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Digital Brain Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Components
      • 6.3.2.2.2. By Functionalities
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Digital Brain Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Components
      • 6.3.3.2.2. By Functionalities
      • 6.3.3.2.3. By End-User

7. Europe Digital Brain Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Components
  • 7.2.2. By Functionalities
  • 7.2.3. By End-User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Digital Brain Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Components
      • 7.3.1.2.2. By Functionalities
      • 7.3.1.2.3. By End-User
  • 7.3.2. France Digital Brain Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Components
      • 7.3.2.2.2. By Functionalities
      • 7.3.2.2.3. By End-User
  • 7.3.3. United Kingdom Digital Brain Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Components
      • 7.3.3.2.2. By Functionalities
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Digital Brain Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Components
      • 7.3.4.2.2. By Functionalities
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Digital Brain Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Components
      • 7.3.5.2.2. By Functionalities
      • 7.3.5.2.3. By End-User

8. Asia Pacific Digital Brain Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Components
  • 8.2.2. By Functionalities
  • 8.2.3. By End-User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Digital Brain Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Components
      • 8.3.1.2.2. By Functionalities
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Digital Brain Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Components
      • 8.3.2.2.2. By Functionalities
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Digital Brain Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Components
      • 8.3.3.2.2. By Functionalities
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Digital Brain Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Components
      • 8.3.4.2.2. By Functionalities
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Digital Brain Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Components
      • 8.3.5.2.2. By Functionalities
      • 8.3.5.2.3. By End-User

9. Middle East & Africa Digital Brain Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Components
  • 9.2.2. By Functionalities
  • 9.2.3. By End-User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Digital Brain Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Components
      • 9.3.1.2.2. By Functionalities
      • 9.3.1.2.3. By End-User
  • 9.3.2. UAE Digital Brain Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Components
      • 9.3.2.2.2. By Functionalities
      • 9.3.2.2.3. By End-User
  • 9.3.3. South Africa Digital Brain Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Components
      • 9.3.3.2.2. By Functionalities
      • 9.3.3.2.3. By End-User

10. South America Digital Brain Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Components
  • 10.2.2. By Functionalities
  • 10.2.3. By End-User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Digital Brain Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Components
      • 10.3.1.2.2. By Functionalities
      • 10.3.1.2.3. By End-User
  • 10.3.2. Colombia Digital Brain Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Components
      • 10.3.2.2.2. By Functionalities
      • 10.3.2.2.3. By End-User
  • 10.3.3. Argentina Digital Brain Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Components
      • 10.3.3.2.2. By Functionalities
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Digital Brain Health Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Advanced Oncotherapy PLC
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cerner Corporation
• 15.3. Core Solutions, Inc.
• 15.4. Danfysik A/S
• 15.5. Hitachi Ltd
• 15.6. Holmusk Inc
• 15.7. IBA Worldwide
• 15.8. Qualifacts Systems, Inc.
• 15.9. International Business Machines Corporation
• 15.10. Linus Health Inc

16. Strategic Recommendations

17. About Us & Disclaimer